Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.

NYSE:BAX

Baxter International Inc

Last Close

39.52

18/04 20:00

Market Cap

20.20B

Beta: 0.56

Volume Today

2.25M

Avg: 6.56M

PE Ratio

7.55

PFCF: 21.00

Dividend Yield

3.01%

Payout:22.57%

Share Trends

Transaction Log

Please Sign In To Use The Chat